|

Weight Loss in Adults Using Semaglutide (Real-world Study)

RECRUITINGSponsored by Novo Nordisk A/S
Actively Recruiting
SponsorNovo Nordisk A/S
Started2026-05-12
Est. completion2026-06-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07627074

Summary

The purpose of the study is to assess the weight loss in participants treated with commercially available semaglutide according to routine clinical practice at the discretion of the treating physician.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Initiation of semaglutide for weight management during the study period.
* Age more than or equal to (≥) 18 at treatment initiation
* Baseline body mass index (BMI) ≥27 and less than (\<) 30 kilogram per meter square (kg/m\^2) with at least one weight-related comorbidity, or BMI ≥30 kg/m\^2.
* Other inclusion criteria as defined in the protocol are applicable.

Exclusion Criteria:

* Prior use of glucagon-like peptide-1 receptor agonist (GLP-1 RA) based medication or other obesity management medication (OMMs).
* Bariatric surgery at baseline.
* Diabetes at baseline.
* Pregnancy at baseline.

Conditions3

ObesityOverweightWeight Loss

Interventions1

Semaglutide

Locations1 site

Novo Nordisk Investigational Site
Seattle, Washington, 98039

Find trials near these locations

Weight Loss trials in SeattleAll trials in Washington

Related trials

Browse More Trials

Weight Loss trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.